세계의 수면무호흡용 의료기기 시장 규모, 점유율 및 성장 분석 : 의료기기 유형별, 최종사용자별 - 산업 예측(2023-2030년)
Global Sleep Apnea Devices Market Size, Share, Growth Analysis, By Device Type(Therapeutic Devices, Diagnostic Devices), By End-User(Sleep Laboratories & Clinics, Homecare & Other Settings) - Industry Forecast 2023-2030
세계의 수면무호흡용 의료기기 시장 규모는 2022년 75억 9,000만 달러에서 2030년까지 138억 4,000만 달러에 이르고, 예측 기간(2023-2030년) 동안 6.9%의 CAGR을 나타낼 것으로 예상됩니다. 비만 및 기타 생활습관 문제 증가, 선진국과 개발도상국 모두에서 수면무호흡증 진단율 증가는 시장 성장을 가속하는 요인입니다.
이 보고서는 세계의 수면무호흡용 의료기기(Sleep Apnea Devices) 시장을 조사 분석하여 시장 역학 및 전망, 부문 분석, 기업 프로파일 등의 정보를 제공합니다.
Sleep Apnea Devices Market size was valued at USD 7.1 billion in 2021 and is poised to grow from USD 7.59 billion in 2022 to USD 13.84 billion by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).
An individual's uneven breathing pattern while they are asleep is a sign of the sleeping disorder sleep apnea. People with untreated sleep apnea experience erratic breathing while they sleep as a result of the brain and the rest of the body receiving insufficient oxygen. The likelihood of having this condition increases with age and the presence of conditions including diabetes, hypertension, cardiovascular disease, and others. The most prevalent type of sleep apnea in the world is obstructive sleep apnea (OSA), and its prevention necessitates early diagnosis and the use of treatment tools.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Apnea Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
The Global Sleep Apnea Devices Market is segmented based on the Device type, End-User, and Region. Based on the Device Type, the Market is segmented into Therapeutic Devices and Diagnostic Devices. Based on the End-User, the Market is segmented as Sleep Laboratories & Clinics and Homecare & Other Settings. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Increase in the Rate of Obstructive Sleep Apnea
People's sedentary lives are contributing to an increase in cardiovascular diseases, inconsistent sleep patterns, high levels of stress, and obesity. The European Respiratory Society reported that between 13% and 32% of Europe's elderly population experience sleep apnea.
Due to increased rates of obesity and other lifestyle issues, as well as rising sleep apnea diagnostic rates in both industrialised and developing countries, a substantial patient pool must be treated or managed for the illness. This is encouraging market growth, along with a rise in sleep clinics and sleep technologists globally.
The market's growth is being constrained by a number of challenges even though the sickness and symptoms connected to a sedentary lifestyle are growing more widespread globally. One of them is the expensive price tag placed on the apparatus. The CPAP and PSG sleep apnea machines are the main alternatives for addressing OSA. A CPAP machine in the US may be quite pricey without health insurance, costing between USD 600 and USD 800. Developed countries have sophisticated infrastructure and payment systems. However, patient compensation systems are inadequate in developing countries, and out-of-pocket costs are substantial. The low penetration of medical coverage in these countries also places a limit on the number of patients obtaining care there.
The trend of patients towards technologically advanced devices has tremendously facilitated the development of new choices for the treatment of sleep apnea. For instance, the use of oral devices like the mandibular advancement device (MAD) for OSA therapy has increased as a result of patient dissatisfaction with CPAP machines.
Since it is non-invasive and more affordable than standard polysomnography equipment (PSG), a portable diagnostic instrument known as an Actometer has gained a lot of popularity in sleep clinics. As a result of rising non-adherence to CPAP equipment and rising desire for reasonably priced diagnostic tools, patients are increasingly resorting to mouth appliances and actometers for effective management of sleep apnea.